These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 7691407

  • 1. Epitope specificity of the anti-(B cell lymphoma) monoclonal antibody, LL2.
    Stein R, Belisle E, Hansen HJ, Goldenberg DM.
    Cancer Immunol Immunother; 1993 Oct; 37(5):293-8. PubMed ID: 7691407
    [Abstract] [Full Text] [Related]

  • 2. Chimerization of LL2, a rapidly internalizing antibody specific for B cell lymphoma.
    Leung SO, Shevitz J, Pellegrini MC, Dion AS, Shih LB, Goldenberg DM, Hansen HJ.
    Hybridoma; 1994 Dec; 13(6):469-76. PubMed ID: 7737671
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Treatment of non-Hodgkin's lymphoma with radiolabeled murine, chimeric, or humanized LL2, an anti-CD22 monoclonal antibody.
    Juweid M, Sharkey RM, Markowitz A, Behr T, Swayne LC, Dunn R, Hansen HJ, Shevitz J, Leung SO, Rubin AD.
    Cancer Res; 1995 Dec 01; 55(23 Suppl):5899s-5907s. PubMed ID: 7493367
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Radioimmunotherapy using 131I-labeled anti-CD22 monoclonal antibody (LL2) in patients with previously treated B-cell lymphomas.
    Lindén O, Tennvall J, Cavallin-Ståhl E, Darte L, Garkavij M, Lindner KJ, Ljungberg M, Ohlsson T, Sjögreen K, Wingårdh K, Strand SE.
    Clin Cancer Res; 1999 Oct 01; 5(10 Suppl):3287s-3291s. PubMed ID: 10541377
    [Abstract] [Full Text] [Related]

  • 12. Phase I/II trial of multiple dose 131Iodine-MAb LL2 (CD22) in patients with recurrent non-Hodgkin's lymphoma.
    Vose JM, Colcher D, Gobar L, Bierman PJ, Augustine S, Tempero M, Leichner P, Lynch JC, Goldenberg D, Armitage JO.
    Leuk Lymphoma; 2000 Jun 01; 38(1-2):91-101. PubMed ID: 10811451
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Monoclonal antibody SN10 which shows a highly selective reactivity with human B leukemia-lymphoma and is effectively internalized into cells.
    Takeuchi T, Barcos MP, Seon BK.
    Cancer Res; 1991 Jun 01; 51(11):2985-93. PubMed ID: 1709587
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.